Singapore markets close in 1 hour 31 minutes
Straits Times Index
3,244.38 +18.93 (+0.59%) Nikkei
27,574.43 -111.97 (-0.40%) Hang Seng
19,435.86 +621.04 (+3.30%) FTSE 100
7,489.19 -32.20 (-0.43%) BTC-USD
16,837.22 +33.66 (+0.20%) CMC Crypto 200
395.42 -6.61 (-1.64%)
Orphazyme A/S (ORPHA.CO)
Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
At close: 04:52PM CET
| Previous close | 1.0600 |
| Open | 1.0750 |
| Bid | 1.0600 x 0 |
| Ask | 1.0890 x 0 |
| Day's range | 1.0500 - 1.1190 |
| 52-week range | 1.0000 - 21.3000 |
| Volume | |
| Avg. volume | 84,742 |
| Market cap | 40.566M |
| Beta (5Y monthly) | 0.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -17.9400 |
| Earnings date | 26 Sept 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.
- Zacks
Orphazyme (ORPH) Up on Plans of NDA Resubmission for Rare Drug
Orphazyme (ORPH) is looking to resubmit its NDA for arimoclomol to the FDA for the treatment of Niemann-Pick disease type C in the United States. Shares rise.
© 2022 Yahoo. All rights reserved.
